RESUMEN
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the cell migration assay data shown in Fig. 2D were strikingly similar to data that had appeared in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 16: 50555061, 2017; DOI: 10.3892/mmr.2017.7167].
RESUMEN
Gastric cancer is the fourth most common malignancy and the third leading cause of cancerassociated deaths worldwide. It has previously been demonstrated that microRNAs (miRNAs) are actively involved in the pathogenesis of gastric cancer. Therefore, miRNAs have been proposed as promising therapeutic targets in gastric cancer patients. MiR744 is aberrantly expressed in different types of human cancer. However, the expression pattern and biological roles of miR744 in gastric cancer remain unknown. The present study demonstrated that miR744 expression was low in gastric cancer tissues and cell lines. Low expression levels of miR744 was significantly correlated with lymph node metastasis, invasive depth and TNM staging in gastric cancer patients. The restoration of miR744 expression inhibited cell proliferation and invasion in vitro. Bioinformatic prediction, luciferase reporter assay, reverse transcriptionquantitative polymerase chain reaction and western blot analysis verified that brainderived neurotrophic factor (BDNF) is a direct target of miR744 in gastric cancer cells. Furthermore, BDNF was upregulated in gastric cancer tissues and inversely correlated with miR744 expression. Furthermore, enforced BDNF expression reversed the tumorsuppressing effects of miR744 on the proliferation and invasion of gastric cancer cells, indicating that BDNF is a functional mediator of miR744 in gastric cancer. The present study suggests that miR744 is a potential prognostic biomarker and treatment target in gastric cancer patients.
Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/genética , MicroARNs/genética , Interferencia de ARN , Neoplasias Gástricas/genética , Regiones no Traducidas 3' , Adulto , Anciano , Línea Celular Tumoral , Movimiento Celular , Proliferación Celular , Biología Computacional/métodos , Femenino , Expresión Génica , Genes Reporteros , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Metástasis de la Neoplasia , Estadificación de Neoplasias , Neoplasias Gástricas/patologíaRESUMEN
A novel multifunctional theranostic agent has been successfully fabricated by loading iron oxide nanoparticles into poly(lactic acid) (PLA) microcapsules followed by surface functionalization with graphene oxide. Both in vitro and in vivo experiments proved that the resulting microcapsules could serve as contrast agents to simultaneously enhance ultrasound, magnetic resonance and photoacoustic imaging. The composite microcapsules show good biocompatibility and rapid response to magnetic fields. Due to the strong absorption of the near-infrared light, the composite microcapsules could efficiently kill cancer cells upon NIR laser irradiation. In addition, it was found that such a photothermal effect could be obviously enhanced by applying an external magnetic field. In a nutshell, this multifunctional microcapsule can be developed as a promising platform that integrates multimodality imaging and therapy capabilities for effective cancer theranostics.
RESUMEN
The aim of this study was to assess the genetic status of cagA, vacA subtype and iceA genotypes of Helicobacter pylori and the relationship with upper gastrointestinal diseases in Northeast China. Gastric biopsies were obtained from 378 patients with upper gastrointestinal diseases and 197 samples were used. The cagA, vacA alleles and iceA genotypes were determined by polymerase chain reaction. CagA was present in 176 (89.3%) of 197 patients. Of the 197 cases, 186 (94.4%) had vacA signal sequence s1c allele, 6 (3%) had s1a and 5 (2.5%) had s1b. The vacA s2 genotype was not detected in our study. VacA middle region sequences, m1 and m2, were found in 20 (10.2%) and 150 (76.1%), respectively. The allelic variant iceA1 (70.1%) was more prevalent than iceA2 (23.4%). The vacA allele s1am2 had a significant relationship with the presence of gastric cancer (p<0.05) and the iceA1 genotype was also associated with gastric cancer (p<0.05). These may be useful risk factors for upper gastrointestinal diseases.
RESUMEN
OBJECTIVE: To evaluate the value of colonoscopy in the diagnosis of colorectal cancer. METHODS: The data of colonoscopy in 1751 patients from May 2003 to June 2006 were retrospectively analyzed. RESULTS: Of these 1751 colonoscopies, 643 colorectal cancers (36.7%) were detected. The age of most patients was between 40 and 60 years, and hematochezia was the major syndrome for these patients. 351 patients (54.6%) had lump type, 211 (32.8%) ulcerous type, 81 (12.6%) ulcerous infiltration type. 511 colorectal cancers (79.5%) originated from the rectum or sigmoid colon. Simultaneous double primary carcinoma was found in 15 cases (2.3%). Multiple primary cancer was observed in 2 cases. Furthermore 254 colorectal cancers (39.5%) were found to have concurrent colorectal polyps. CONCLUSION: Colonoscopy of total colon and rectum is very helpful in diagnosis of colorectal cancer, which can reduce the rate of misdiagnosis and improve the survival.
Asunto(s)
Adenocarcinoma/diagnóstico , Colonoscopía/métodos , Neoplasias Colorrectales/diagnóstico , Neoplasias Primarias Múltiples/diagnóstico , Adenocarcinoma/patología , Colon/patología , Pólipos del Colon/diagnóstico , Pólipos del Colon/patología , Neoplasias Colorrectales/patología , Errores Diagnósticos , Femenino , Hemorragia Gastrointestinal/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Recto/patología , Estudios RetrospectivosRESUMEN
OBJECTIVE: To observe the effect of transcutaneous electrical acupoint stimulation (TEAS) on nausea and vomiting (N&V) induced by patient controlled intravenous analgesia (PCIA) with Tramadol. METHODS: Sixty patients who were ready to receive scheduled operation for tumor in the head-neck region and post-operation PCIA, aged 39-65 years, with the physique grades I-II of ASA, were randomized into two groups, A and B, 30 in each group. The pre-operation medication, induction of analgesia and continuous anesthesia used in the two groups were the same. TEAS on bilateral Hegu (LI4) and Neiguan (PC6) points was intermittently applied to the patients in group A starting from 30 min before analgesia induction to 24 h after operation, and the incidence and score of nausea and vomiting, antiemetic used, visual analogue scores (VAS), and PCIA pressing times in 4 time segments (0-4, 4-8, 8-12 and 12-24 h after the operation was finished) were determined. The same management was applied to patients in Group B, with sham TEAS for control. RESULTS: The incidence and degree of N&V, as well as the number of patients who needed remedial antiemetic in Group A were less than those in Group B. The VAS score and PCIA pressing time were lower in Group A than those in Group B in the corresponding time segments respectively. CONCLUSION: TEAS could prevent N&V induced by PCIA with Tramadol.